Molina Healthcare (NYSE:MOH) Sets New 12-Month Low on Disappointing Earnings

Molina Healthcare, Inc (NYSE:MOH)’s share price hit a new 52-week low during trading on Friday following a dissappointing earnings announcement. The stock traded as low as $125.00 and last traded at $131.6530, with a volume of 2149438 shares. The stock had previously closed at $176.84.

The company reported ($2.75) EPS for the quarter, missing analysts’ consensus estimates of $0.43 by ($3.18). The company had revenue of $11.38 billion during the quarter, compared to analysts’ expectations of $10.90 billion. Molina Healthcare had a return on equity of 13.37% and a net margin of 1.04%.Molina Healthcare’s revenue for the quarter was up 8.3% compared to the same quarter last year. During the same quarter last year, the firm posted $5.05 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS.

Key Stories Impacting Molina Healthcare

Here are the key news stories impacting Molina Healthcare this week:

• Positive Sentiment: Q4 revenue beat — Molina reported $11.38B in Q4 sales, up ~8% year-over-year and above consensus, showing top-line growth despite cost pressures. Molina Healthcare Reports Fourth Quarter and Year-End 2025 Financial Results
• Positive Sentiment: High-profile investor support — Michael Burry has reportedly remained positive on MOH, which could attract contrarian interest and buying at lower levels. Should You Buy the Dip in This Oversold Michael Burry Stock?
• Neutral Sentiment: Earnings call transcript available — Management discussed drivers of the quarter and outlook on the Q4 earnings call; review for details on cost trends and segment performance. Molina Healthcare, Inc. Q4 2025 Earnings Call Transcript
• Negative Sentiment: Massive EPS miss — Molina reported a surprise Q4 loss of ($2.75) per share vs. an expected ~$0.43, a swing that shocked investors and eroded confidence in near-term profitability. Molina (MOH) Reports Q4 Loss, Tops Revenue Estimates
• Negative Sentiment: Severe guidance cut — Management set FY2026 EPS guidance around $5.00 vs. analyst consensus near $12.95, signaling continued margin pressure (driving much of today’s selloff). Molina Healthcare forecasts 2026 profit below estimates
• Negative Sentiment: Rising medical costs & exchange headwinds — Management cited surging medical costs in its ACA/exchange business and policy uncertainty as key drags on profit recovery. Molina Healthcare Incurs a Loss in Q4 as Medical Costs Surge
• Negative Sentiment: Analyst reaction and downgrades — Street reaction includes cuts and a reiterated sell/underperform with lower price targets, increasing downside risk near term. Molina Healthcare: Slashed Earnings Outlook, Exchange Contraction, and Policy Uncertainty Drive Underperform (Sell) Rating
• Negative Sentiment: Market reaction — Major outlets report the stock plunged on the surprise loss and weak outlook, with heavy trading volume as investors reprice risk. Molina plunges after issuing 2026 profit forecast much below expectations

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on MOH shares. The Goldman Sachs Group lowered their target price on shares of Molina Healthcare from $207.00 to $167.00 and set a “neutral” rating for the company in a report on Friday, October 24th. Weiss Ratings reissued a “sell (d+)” rating on shares of Molina Healthcare in a research report on Thursday, January 22nd. Morgan Stanley set a $158.00 target price on Molina Healthcare in a research report on Friday, October 24th. Truist Financial set a $175.00 target price on Molina Healthcare in a research note on Friday, October 24th. Finally, Wells Fargo & Company raised their price target on Molina Healthcare from $165.00 to $208.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 7th. Three research analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $182.64.

Insider Buying and Selling at Molina Healthcare

In related news, Director Richard M. Schapiro sold 357 shares of the business’s stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $143.02, for a total value of $51,058.14. Following the completion of the sale, the director owned 11,352 shares in the company, valued at approximately $1,623,563.04. The trade was a 3.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.10% of the company’s stock.

Institutional Investors Weigh In On Molina Healthcare

Institutional investors and hedge funds have recently bought and sold shares of the company. Baird Financial Group Inc. purchased a new position in shares of Molina Healthcare during the first quarter valued at $210,000. NewEdge Advisors LLC grew its holdings in Molina Healthcare by 33.4% during the 1st quarter. NewEdge Advisors LLC now owns 1,106 shares of the company’s stock worth $364,000 after acquiring an additional 277 shares in the last quarter. Jones Financial Companies Lllp increased its position in Molina Healthcare by 713.3% during the 1st quarter. Jones Financial Companies Lllp now owns 1,651 shares of the company’s stock valued at $544,000 after purchasing an additional 1,448 shares during the period. Goldman Sachs Group Inc. raised its holdings in shares of Molina Healthcare by 19.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 249,466 shares of the company’s stock valued at $82,172,000 after purchasing an additional 40,531 shares in the last quarter. Finally, Woodline Partners LP purchased a new stake in shares of Molina Healthcare in the 1st quarter worth approximately $1,541,000. 98.50% of the stock is owned by institutional investors.

Molina Healthcare Price Performance

The company has a current ratio of 1.68, a quick ratio of 1.68 and a debt-to-equity ratio of 0.92. The firm’s 50-day moving average price is $173.19 and its two-hundred day moving average price is $170.90. The stock has a market cap of $7.14 billion, a PE ratio of 15.39 and a beta of 0.49.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.